Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2025

Genmab — September 2025

Planlagt Fastgjort Låst Flyttet Genmab
283 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #184

    it does put some additional perspective on why some early clinical trials were deemed not good enough to proceed

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #185

      Vil undre mig meget hvis det ikke koster dyrt på kursen.

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #186

        Yes EL that was rettidigt omhu, as we say kn Denmark.

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #187

          It sures raises some attention to Gmab with this size of M&A. And with the very succesfull Profound deal in the bag, hopefully market will trust Gmab judgement this time.

          1 Reply Last reply
          0
          • B Offline
            B Offline
            BuyLow
            wrote on sidst redigeret af
            #188

            The offices of Merus and Genmab are next to each other in Utrecht. They know each other well. GMAB has 3Bn cash, earning 1Bn a year, rising to 1,5Bn per year
            in 2028. They can easily fund the debt based on recurring cashflow.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #189

              they are actually in the same building...

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #190

                14/10 09:24
                af E L
                The new building next to the (also rather new...) Genmab R&D Center in Utrecht was opened. it will house Genmab, Merus and ImmunoPrecise Antibodies https://vastgoedberichten.nl/2023/10/13/kadans-opent-innovatiecentrum-accelerator-utrecht-op-utrecht-science-park/

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #191

                  Have we heard anything from the IPA collaboration ?

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #192

                    Markedet er meget uenige om

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #193

                      Det bør koste på kursen pga af størrelsen af købet.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #194

                        Genmab skal for første gang gældsætte sig eller sælge aktier for at finansiere købet.

                        1 Reply Last reply
                        0
                        • nohopeN Offline
                          nohopeN Offline
                          nohope
                          wrote on sidst redigeret af
                          #195

                          I bedste fald er udbytte eller tilbagekøb udskudt mindst 5 år.

                          1 Reply Last reply
                          0
                          • T Offline
                            T Offline
                            transalp
                            wrote on sidst redigeret af
                            #196

                            Men tror vi på genmab, er det jo mere menig i udvidelse, snare end udbytte og tilbagekøb. Men giver en lille trækning, når man tænker på fabrikken i USA..

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              lahn1
                              wrote on sidst redigeret af
                              #197

                              @buylow, ja de kommer hurtigt ned på et acceptabelt gældsniveau som de selv siger mindre end 3 i 2027. Darzalex royalties lægger en sikker bund og øger troværdigheden af tilbagebetalingen af lånet.

                              1 Reply Last reply
                              0
                              • nohopeN Offline
                                nohopeN Offline
                                nohope
                                wrote on sidst redigeret af
                                #198

                                Tror vi på Jan? Ham der sagde at vi ville få ret i voldgifterne ? Ham der ville forklare JnJ at de skulle købe SuperDara ?

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #199

                                  @transalp, med Profound bio frisk i mente og Gmabs evne til at se guldet før andre, kan vi jo håbe at de igen har snuppet en usleben diamond for næsten af de store drenge i klassen.

                                  1 Reply Last reply
                                  0
                                  • T Offline
                                    T Offline
                                    transalp
                                    wrote on sidst redigeret af
                                    #200

                                    Yes lahn1. Det lydervikk som det er et "ukendt" firma, for dem..

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #201

                                      Genmab: "Fornuftig køb til høj pris https://proinvestor.com/boards/128617

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #202

                                        Merus CEO: We’re really optimistic about the potential for our drug in head and neck cancer https://www.youtube.com/watch?v=4UBXaksMRAQ

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #203

                                          Genmabs gigantopkøb rummer kæmpe potentiale mener Sydbank-analytiker https://proinvestor.com/investornyt/1366125/genmabs-gigantopkob-rummer-kaempe-potentiale-mener-sydbank-analytiker

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper